Molecular Diagnostics Market Industry Analysis and Opportunity and Forecast To 2029
Description
Data Bridge Market
Research analyses that the molecular diagnostics market, which was USD 20.1 billion in 2022, would rise to
USD 54.76 billion by 2030 and is expected to undergo a CAGR of 13.3% during the
forecast period from 2023 to 2030. In addition to the insights on market
scenarios such as market value, growth rate, segmentation, geographical
coverage, and major players, the market reports curated by the Data Bridge
Market Research also include depth expert analysis, patient epidemiology,
pipeline analysis, pricing analysis, and regulatory framework.
The growing incidence of infectious diseases and
cancer globally has increased the adoption of molecular diagnostics. The major
market players are now primarily focused on technological advances in molecular
diagnostics. Also, it has been witnessed during COVID-19 that the diagnostics
industry faced much growth, with a race to develop novel and rapid diagnostics
kits for the detection of coronavirus. In 2021, a 59% rise in revenue was
reported by Thermo Fisher Scientific due to the diagnostics division that
delivered 150% growth.
Request Access for Molecular Diagnostics
Market
Sample
Report: https://www.databridgemarketresearch.com/reports/global-molecular-diagnostics-market
Market Analysis and Insights: Global Molecular Diagnostics
Market
Molecular diagnosis can detect the diseases such as hereditary
diseases, infectious diseases, neurological diseases, cardiovascular diseases,
and others by examining molecules such as DNA, RNA, and protein in a tissue or
a fluid. Numerous methods, such as mass spectrometry, PCR, next-generation
sequencing, in situ hybridization, molecular imaging, and others, are used to
diagnose several diseases. Molecular diagnostics uses strong technologies such
as DNA sequence analysis, gene expression profiling, and biomarker
identification to identify disorders correctly.
The increasing geriatric population worldwide is
surging the risk of getting several diseases, such as cardiovascular diseases,
cancer, obesity, neurological disorders, and diabetes. As per the UN report, in
2020, there were around 727 million people aged 65 years and above worldwide.
In addition to this, the number of individuals aged 80 years and above is
anticipated to double by 2050. The geriatric population is more likely to
suffer from multiple diseases due to multimorbidity, decreased immune function,
and aging-related physiological changes. Thus, this factor boosts market
growth.
Access Full Report:- https://www.databridgemarketresearch.com/reports/global-molecular-diagnostics-market
Molecular Diagnostics Market Scope and Market
Size
The molecular diagnostics market is segmented on the
basis of products, technology, application and end user. The growth amongst
these segments will help you analyze meagre growth segments in the industries
and provide the users with a valuable market overview and market insights to
help them make strategic decisions for identifying core market applications.
Products
- Reagents
and Kits
- Instruments
- Services
and Software
Technology
- Mass
Spectrometry (MS)
- Capillary
Electrophoresis
- Next
Generation Sequencing (NGS)
- Chips
and Microarray
- Polymerase
Chain Reaction (PCR)-Based Methods
- Cytogenetics
- In Situ
Hybridization (ISH or FISH)
- Molecular
Imaging
- Others
Application
- Oncology
- Breast
Cancer
- Colorectal
Cancer
- Lung
Cancer
- Prostate
Cancer
- Other
Cancers
- Pharmacogenomics
- Microbiology
- Prenatal
Tests
- Tissue
Typing
- Blood
Screening
- Cardiovascular
Diseases
- Neurological
Diseases
- Infectious
Diseases
- COVID-19
- Hepatitis
- HIV
- CT/NG
- HAI
- HPV
- Tuberculosis
- Influenza
- Others
- Others
End User
- Hospital
- Clinical
Laboratories
- Academics
Get TOC of the Report: https://www.databridgemarketresearch.com/toc/?dbmr=global-molecular-diagnostics-market
Major TOC of the Molecular Diagnostics Market Report
Chapter One:
MARKET SEGEMENTATION
EXECUTIVE SUMMARY
PREMIUM INSIGHTS
MARKET OVERVIEW
Molecular Diagnostics Market Scope Country Level
Analysis
The molecular diagnostics market is analyzed and
market size insights and trends are provided by products, technology, application
and end user as referenced above.
The countries covered in the molecular diagnostics
market report are U.S., Canada, and Mexico in North America, Germany, France,
U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of
Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia,
Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the
Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of
Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil,
Argentina and Rest of South America as part of South America.
Competitive Landscape and Molecular Diagnostics Market Share
Analysis
The molecular diagnostics market competitive landscape
provides details by competitor. Details included are company overview, company
financials, revenue generated, market potential, investment in research and
development, new market initiatives, global presence, production sites and
facilities, production capacities, company strengths and weaknesses, product
launch, product width and breadth, application dominance. The above data points
provided are only related to the companies' focus related to molecular
diagnostics market.
The major players
covered in Molecular Diagnostics market report are
- F.
Hoffmann-La Roche Ltd(Switzerland)
- Hologic,
Inc., (U.S.)
- bioMérieux
(France)
- Abbott
(U.S.)
- QIAGEN
(Netherlands)
- Thermo
Fisher Scientific (U.S.)
- Siemens
(Germany)
- Danaher
(U.S.)
- Myriad
Genetics Inc. (U.S.)
- Illumina
Inc. (U.S.)
- Agilent
Technologies Inc. (U.S.)
- BD
(U.S), DiaSorin S.p.A (Italy)
- Grifols
S.A. (Spain)
- Quidel
Corporation(U.S.)
- Genetic
Signatures (Australia)
- MDxHealth,
Inc. (U.S.)
- Exact
Sciences Corporation (U.S.)
- Biocartis
(Belgium)
- TBG
Diagnostics Limited (Australia)
- GenMark
Diagnostics Inc. (U.S.)
- Luminex
Corporation (U.S.)
- HTG
Molecular Diagnostics Inc. (U.S.)
- Vela
Diagnostics (Singapore)
- Amoy
Diagnostics Co., Ltd. (China)
- Molbio
Diagnostics Pvt. Ltd. (India)
- geneOmbio
(India)
Browse
Related Reports @
Global Instant Noodles Market – Industry Trends and Forecast to 2031 https://www.databridgemarketresearch.com/reports/global-instant-noodles-market
Global Energy Drinks Market https://www.databridgemarketresearch.com/reports/global-energy-drinks-market
Global Central Fill Pharmacy Automation Market https://www.databridgemarketresearch.com/reports/global-central-fill-pharmacy-automation-market
Global Power and Energy Manufacturing Analytics Market https://www.databridgemarketresearch.com/reports/global-power-and-energy-manufacturing-analytics-market
Global Drop Shipping Market https://www.databridgemarketresearch.com/reports/global-drop-shipping-market
Global Blockchain Smartphones Market https://www.databridgemarketresearch.com/reports/global-blockchain-smartphones-market
Global Float Zone Silicon Market https://www.databridgemarketresearch.com/reports/global-float-zone-silicon-market
Global N-Butanol market https://www.databridgemarketresearch.com/reports/global-n-butanol-market
About Us:
Data
Bridge Market Research set forth itself as an
unconventional and neoteric Market research and consulting firm with
unparalleled level of resilience and integrated approaches. We are determined
to unearth the best market opportunities and foster efficient information for
your business to thrive in the market
Contact:
Data
Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Comments
Post a Comment